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Abstract: 
Background: Life review interventions have been used to alleviate psycho-
spiritual distress in people near the end of life. However, their effectiveness 
remains inconclusive.  
Aim: To evaluate the effects of therapeutic life review on spiritual well-
being, psychological distress, and quality of life (QOL) in patients with 
terminal or advanced cancer.  
Design: A systematic review according to the PRISMA methodology.  
Data sources: Five databases were searched from their respective 
inception through August 2016 for relevant randomized controlled trials 
(RCTs). The effects of therapeutic life review were pooled across the trials. 
Standardized mean differences (SMDs) were calculated for the pooled 
effects. Heterogeneity was assessed using the I2 test. Study quality was 
assessed using the Cochrane criteria.  
Results: Eight RCTs met the inclusion criteria. The pooled results suggested 
a desirable effect of therapeutic life review on the meaning of life domain 
of spiritual well-being (SMD = 0.33; 95% CI, 0.12 to 0.53), general 
distress (SMD = -0.32; 95% CI, -0.55 to -0.09) and overall QOL (SMD = 
0.35; 95% CI, 0.15 to 0.56) when compared to usual care only. Of the 
three outcomes examined, only the pooled effect on overall QOL remained 
statistically significant at follow-ups up to 3 months after the intervention 
(SMD = 0.82; 95% CI, 0.47 to 1.18).  
Conclusions: Therapeutic life review is potentially beneficial for people near 
the end of life. However, the results should be interpreted with caution due 
to the limited number of RCTs and associated methodological weaknesses. 
Further rigorously designed RCTs are warranted.  
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What is already known about the topic?  
• Life review therapy has been applied for depression in the elderly for a long time; only in 
recent years has it been used to relieve psycho-existential suffering of people facing death. 
• Therapeutic life review can delivered on the basis of different concepts such as dignity, 
meaning, forgiveness, and life completion. 
• An increasing number of clinical trials have examined the efficacy and effectiveness of 
therapeutic life review in palliative care, but the findings are inconsistent.  
What this paper adds? 
• This paper presents the cumulative evidence from well-designed clinical trials of the 
effectiveness of therapeutic life review in palliative care. 
• The available evidence suggest favorable effects of therapeutic life review on the meaning of 
life domain of spiritual well-being, general distress, and overall quality of life.  
• This paper points out that further well-designed multi-centered studies are warranted. 
Implications for practice, theory, or policy  
• Therapeutic life review appears to hold promise as a psych-existential intervention for 
individuals near the end of life. 
• It may be necessary to integrate therapeutic life review into end-of-life care practice so as to 
enhance the psycho-spiritual well-being of terminally ill patients. 
• Given that therapeutic life review is often delivered in an individualized approach and a 
flexible way for terminally-ill individuals, a practical guideline to maintain an adequate 
degree of standardization may be required.   
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Abstract 
Background: Life review interventions have been used to alleviate psycho-spiritual distress in 
people near the end of life. However, their effectiveness remains inconclusive.  
Aim: To evaluate the effects of therapeutic life review on spiritual well-being, psychological 
distress, and quality of life (QOL) in patients with terminal or advanced cancer. 
Design: A systematic review according to the PRISMA methodology.  
Data sources: Five databases were searched from their respective inception through August 
2016 for relevant randomized controlled trials (RCTs). The effects of therapeutic life review 
were pooled across the trials. Standardized mean differences (SMDs) were calculated for the 
pooled effects. Heterogeneity was assessed using the I2 test. Study quality was assessed using 
the Cochrane criteria.  
Results: Eight RCTs met the inclusion criteria. The pooled results suggested a desirable effect 
of therapeutic life review on the meaning of life domain of spiritual well-being (SMD = 0.33; 
95% CI, 0.12 to 0.53), general distress (SMD = -0.32; 95% CI, -0.55 to -0.09) and overall QOL 
(SMD = 0.35; 95% CI, 0.15 to 0.56) when compared to usual care only. Of the three outcomes 
examined, only the pooled effect on overall QOL remained statistically significant at follow-
ups up to 3 months after the intervention (SMD = 0.82; 95% CI, 0.47 to 1.18).  
Conclusions: Therapeutic life review is potentially beneficial for people near the end of life. 
However, the results should be interpreted with caution due to the limited number of RCTs and 
associated methodological weaknesses. Further rigorously designed RCTs are warranted. 
Keywords: cancer, end of life care, life review, oncology, palliative care, psychotherapy, quality 
of life, spirituality, systematic review  
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Background 
Existential suffering is a major concern for many persons near the end of life, especially for 
those with a terminal illness and possible premature death.1 It is “the distressed state of 
individuals confronting their own mortality and arising from the consequent feelings of 
powerlessness, hopelessness, meaninglessness, futility, remorse, death anxiety, and disruption 
of personal identity” (p.1022).2 Thus, it is one of the most important factors that contribute to 
decreased QOL among those approaching death.3 If left unattended, it may result in anxiety, 
depression, desire for a hastened death, and suicidal ideation.1, 4 Existential or spiritual distress 
not only adds to patient and family suffering, but also presents a huge challenge for care 
professionals in the provision of end-of-life care.2, 5, 6    
According to World Health Organization, relief of existential suffering in terminally ill patients 
is a major component of palliative care - an approach aiming to improve the QOL of patients 
and their families facing the problems associated with a life-threatening illness through 
prevention and relief of suffering as well as treatment of pain and other physical, psychosocial, 
and spiritual problems.7 It is increasingly emphasized by care professionals, dying persons and 
family members. Practically, existential or spiritual concerns can be addressed using different 
approaches. In addition to the traditional approach which is often related to religious practice 
and connects human experience to nature and to the significant or sacred, therapeutic life 
review, which helps the patients to experience their connectedness to the moment, self and 
others so as to find meaning and purpose in one’s life, is considered an effective psycho-
spiritual intervention to alleviate existential/spiritual distress for people facing the challenge of 
death. It is a process of recalling, reevaluating, and reintegrating life experiences in the final 
stage of life.8, 9 Unlike reminiscence which focuses on recalling memorable and pleasurable 
events from the past, therapeutic life review includes the intention of resolving and integrating 
past conflicts, thus giving new significance to an individual’s life and bringing peace to the 
individual.8-10 Various studies indicated that life review therapy might reduce depression in the 
elderly, enhance their life satisfaction, self-esteem, and QOL.11-14   
According to a process model,15 the beneficial effects of life review can be achieved through 
three different pathways: life completion, burden relief, and hope promotion. First, through 
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reviewing their life history, family lives, attainments and social roles, patients can achieve 
personally meaningful goals and confirm self-identity and/or self-continuity, resulting in 
increased feeling of life completion and peace as well as elevated spiritual well-being. Second, 
through reviewing memories of bringing up children and taking care of family members, 
patients can view their present state with balance, which may decrease their feeling of being a 
burden and thus relief psychological distress. Finally, life review interviews may improve 
patients’ feelings about relationships with family members through a review of life history and 
allow patients to look forward to their progeny’s future growth and increase their hope. The 
beneficial effect on hope has been evident among patients with advanced cancer.16   
In recent years, an increasing number of clinical trials have examined the effects of therapeutic 
life review on different health outcomes among terminally ill patients, but the findings are 
inconsistent. Two systematic reviews have summarized relevant studies in the field,9, 17 but the 
results of those studies have not been synthesized. The effectiveness of therapeutic life review 
on health for terminally ill patients remains inconclusive. To date, the literature lacks a 
systematic review and meta-analysis of the clinical trial evidence in this field. To facilitate 
evidence-based end-of-life care practices, results of relevant clinical trials must be pooled. 
Thus, the purpose of this systematic review was to critically assess and synthesize the clinical 
evidence available from RCTs of the effects of therapeutic life review interventions on spiritual 
well-being, psychological distress, and QOL among patients with terminal or advanced cancer. 
Methods 
This review followed the procedure recommended by the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement.18 
Eligibility criteria 
The following criteria were applied for study selection. (1) Types of studies. All RCTs 
evaluating the effects of therapeutic life review on different health outcomes among patients 
with terminal or advanced cancer were included. Nonrandomized controlled trials and 
uncontrolled observational studies were excluded. (2) Types of participants. Study population 
of the intervention should be cancer patients near the end of life and aged 18 years and older. 
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Studies that included newly diagnosed cancer patients, usually at stage I or II, were excluded. 
Studies that included a substantial proportion of the patients with non-cancer terminal illness 
(>10%) were also excluded due to disparities in trajectories of decline leading to death and in 
physical and mental conditions.19 (3) Types of intervention. Given the focus of this review on 
therapeutic life review in particular, rather than on spiritual interventions or psychotherapies in 
general, we excluded the studies that addressed here-and-now issues and the studies that 
connected the patients to nature or to the sacred, as well as the studies of reminiscence. As an 
individual approach was often applied in clinical practice to ensure that the patients felt free to 
reveal their life experiences, studies of group therapy were excluded. (4) Types of controls. All 
included studies had to include a control group of either no psychological intervention or a 
placebo intervention. (5) Types of outcomes. The included studies should include such 
outcomes as spiritual well-being, psychological distress, and/or QOL.  
The literature search 
The following electronic databases were searched initially in August 2016 and re-searched in 
February 2017: CINAHL, Cochrane Library, PsycINFO, PubMed, and Web of Science. The 
following terms were used with such a search string: ‘‘(life review or meaning of life 
intervention or meaning-making intervention or meaning reconstruction or narrative therapy or 
meaning-centered psychotherapy or preparation and life completion or dignity therapy or 
forgiveness therapy or legacy activities or reflective journaling or outlook or story-telling) and 
(terminally ill or seriously ill or life-threatening or end of life or palliative care or advanced 
cancer or advanced-stage cancer).” These terms were identified from relevant articles and 
review papers. We searched the databases for articles containing these terms in the title, abstract 
or keywords from their respective inception through February 2017. Although this review 
mainly included studies published in English, studies in other languages with abstracts in 
English were also examined if available. The reference lists of all included studies and relevant 
reviews were searched manually for other articles.  
Data extraction and quality assessment 
Study selection, data extraction and quality assessment were conducted by one main researcher 
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(CW) and then verified by other researchers (AC, CC). Any discrepancies were resolved by 
discussion. From each of the included trials, we extracted the following information: type of 
participants, number of participants, type of intervention; dosage of the intervention, duration 
of follow up, type of control, outcomes, and results. For the results of each trial, we extracted 
the data on mean, standard deviation and sample size for each outcome in each group at post-
intervention and at follow-up for meta-analyses. Where median and range rather than mean and 
standard deviation were presented, the trial was not included in meta-analyses due to data 
incompatibility. Where the intervention group was compared with two different control groups 
(standard palliative care, client-centered care), we extracted the data of the control group with 
standard palliative care for meta-analysis. The data of another control group were not extracted 
since they might not be comparable with relevant data from other trials. Where outcomes were 
measured at more than one time-point during the follow-up, we used the data at the last time-
point for meta-analyses of follow-up data. For expected but unavailable outcome data, we 
contacted the correspondence author via e-mail for more information.  
The TIDieR (Template for Intervention Description and Replication) checklist20 was used to 
assess the quality of intervention description in each article. The checklist contains 12 items, 
including the intervention name; intervention rationale; information materials used in the 
intervention, intervention procedures; intervention providers; mode of delivery of intervention; 
location of intervention delivery; frequency, intensity and dose of the intervention; intervention 
tailoring; intervention modiﬁcations; intervention ﬁdelity assessment, and actual intervention 
adherence. The Cochrane Collaboration’s assessment tool21 was used to assess the quality of 
whole study for each trial. This tool assesses study quality based on seven criteria: adequate 
randomization; allocation concealment; blinding of participants, personnel, and outcome 
assessors; incomplete outcome data reporting; intention-to-treat analysis; selective outcome 
reporting; and other bias. Since blinding both participants and personnel are generally 
impossible for studies of face-to-face interventions, we only assessed if the outcome assessors 
were blind to the treatment allocation. Based on these criteria, four major categories of bias 
could be evaluated: selection bias (biased allocation), performance bias (unequal provision of 
care apart from the intervention), detection bias (biased assessment of outcomes), and attrition 
bias (biased occurrence of loss to follow up).21 Reporting bias was assessed by examining 
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whether all expected outcome data were reported. “Other bias” was mainly assessed according 
to sample size justification, protocol registration, and other relevant information. 
Data synthesis and analysis 
The reported effects of intervention on each outcome in relevant RCTs were separately pooled 
using Review Manager 5.3 (http://ims.cochrane.org/revman). Standardized mean differences 
(SMDs) were calculated for the pooled effects, which were interpreted using the following rule 
of thumb: 0.2 represents a small effect, 0.5 a moderate effect, and 0.8 a large effect.22 A fixed-
effects model was used when an outcome was measured by the same instrument in different 
studies, and a random-effects model was used for data synthesis when an outcome was 
measured by different measures. Heterogeneity was tested with the I2 statistic. A I2 value of less 
than 75% were considered as high degree of heterogeneity, 50-75% as moderate, and 25-50% 
as low degree of heterogeneity.23 Sensitivity was examined by assessing the impact of a single 
study on the pooled overall effect through omitting one study in turn. Publication bias was not 
assessed due to the limited number of trials (< 10) included in each analysis.21  
Results 
Results of the literature search 
Our searches identified 1387 records. After removal of duplications, 1012 records remained. Of 
them, 986 records were excluded after screening titles and abstracts. Full reports of 26 
publications were acquired and 17 publications were further excluded, including 6 uncontrolled 
trials,10, 24-28 1 study with quasi experimental design,29 1 study with yoked control design,30 and 
9 RCTs that did not meet the inclusion criteria31-39 (Figure 1). 
Characteristics of included studies 
Nine reports on 8 RCTs published between 2010 and 2014 met the inclusion criteria. They were 
conducted in Canada,40, 41 Hong Kong,42 Japan,15 Mainland China,43 Portugal,44, 45 UK,16 and 
USA.46 All of them were published in English in peer-reviewed journals. Table 1 presents the 
characteristics of the included RCTs.  
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All included RCTs focused on patients with terminal or advanced cancer. The sample sizes 
ranged from 28 to 441, with a median of 80 and a total of 955 participants, including 427 in the 
intervention groups and 528 in the control groups, respectively. The types of intervention 
included short-term life-review,15 life review,43 dignity therapy,16, 41, 44, 45 meaning-making 
intervention,40 meaning of life intervention,42 and meaning-centered psychotherapy.46 
Frequencies of intervention ranged from single session40 to seven sessions,46 with 2 sessions in 
four RCTs15,16,42,44 and 3 sessions in two RCTs.41,43 The participants were followed up in 6 
RCTs16,40,42-44,46 for a period of time ranging from 2 weeks42 to 3 months.40  
Nearly all of the included RCTs used a two-armed, parallel-group design, except one with three 
arms. The intervention groups were usually compared with standard palliative care or usual 
care groups. Only in one RCT, the life review intervention was compared to therapeutic 
massage.46 Outcomes were measured at two time points (including baseline) in two RCTs,15, 41 
at three time points in 5 RCTs,16, 40, 42, 43, 46 and at four time points in one RCT.44 Spiritual well-
being was assessed with the Functional Assessment of Chronic Illness Therapy-Spiritual 
(FACIT-Sp) Scale.15, 40, 41, 46 Psychological distress was assessed with the Hospital Anxiety and 
Depression scale (HADS).15, 16, 40, 44, 46 QOL was evaluated with different measures, including a 
single-item QOL scale,43 a 2-item QOL scale,16, 41 EuroQol five dimensions questionnaire (EQ-
5D),16 the McGill Quality of Life Questionnaire (MQOL),40, 46 and Quality-of-Life Concerns in 
the End-of-Life questionnaire (QOLC-E).42, 43    
Pooled effects of the life review therapies on different outcomes  
Meta-analyses of the data were performed for 7 RCTs. Two publications on the same RCT were 
not included in the meta-analyses since the data with median and range rather than mean and 
standard deviation were presented in the publications.44, 45 In another RCT,46 the participants in 
the control group who received physical massage could be taken as those who received a 
placebo intervention. Although there is evidence that the use of massage therapy may reduce 
pain, anxiety and depression in oncological palliative care patients,47  a RCT with terminally ill 
patients produced no evidence of benefit from massage, when evaluated with measures of 
global QOL and pain distress over the course of patient participation.48 Moreover, there is no 
evidence of any effect of massage on spiritual well-being so far. Thus, the data of this group 
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were pooled with relevant data from other RCTs.  
(1) Spiritual well-being  
Four RCTs15, 40, 41, 46 examined the effect of therapeutic life review on spiritual well-being. Of 
them, 3 RCTs15, 40, 46 suggested a beneficial effect on the meaning domain and one RCT46 
suggested a beneficial effect on the faith domain of spiritual well-being immediately at post-
intervention. Only one RCT suggested that the beneficial effect on the meaning domain 
remained 3 months later.40 Their results were pooled, respectively. The pooled effect size was 
statistically significant only for the meaning domain at post-intervention (SMD = 0.33; 95% CI, 
0.12 to 0.53; p = 0.002). There was a high degree of heterogeneity (I2 = 91%, Figure 2). After 
excluding the trial by Ando et al.,15 the pooled effect become insignificant (SMD = 0.10; 95% 
CI, -0.12 to 0.32; p = 0.36; I2 = 30%). Exclusion of any other single trial did not significantly 
alter the pooled effect. 
(2) Psychological distress  
Six RCTs15, 16, 40, 41, 44, 46 examined the effects of life review therapies on psychological distress. 
Of them, only one15 suggested a desirable effect on general distress as indicated by the total 
score of HADS and another RCT44 suggested beneficial effects on both anxiety and depression 
symptoms at post-intervention. No beneficial effect on psychological distress was observed at 
follow-up in any RCT. Apart from one RCT in which the data with median and range were 
presented,44 the results of these trials were pooled for each outcome, and the pooled effect size 
was statistically significant only for general distress levels at post-intervention (SMD = -0.32; 
95% CI, -0.55 to -0.09; p = 0.007). There was a high degree of heterogeneity (I2 = 93%, Figure 
2). After excluding the trial by Ando et al.,15 the pooled effect size become insignificant (SMD 
= -0.03; 95% CI, -0.29 to 0.22; p = 0.79, I2 = 4%). Exclusion of any other single trial did not 
significantly alter the pooled effect.  
(3) Quality of life  
Six RCTs16, 40-43, 46 examined the effect of life review therapies on QOL. A single-item or 2-item 
scale was applied in 4 RCTs and a validated scale was applied in 5 RCTs (Table 1). The total 
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score of the validated scale was not available in one RCT.43 The available results from these 
RCTs were pooled. The pooled effect size was statistically significant for overall QOL 
measured with single-item or 2-item scales at post-intervention (SMD = 0.35; 95% CI, 0.15 to 
0.56; p < 0.001) and at follow-ups (SMD = 0.82; 95% CI, 0.47 to 1.18; p < 0.0001). There was 
a high degree of heterogeneity (I2 = 91% and 90%, respectively, Figure 2). After excluding the 
trial by Xiao et al.,43 the pooled effect sizes for overall QOL become insignificant at post-
intervention (SMD = 0.10; 95% CI, -0.13 to 0.32; p = 0.40; I2 = 0%) and at follow-ups (SMD = 
0.04; 95% CI, -0.45 to 0.53; p = 0.88; I2 = 0%). Exclusion of any other single trial did not 
significantly alter the pooled effect. The pooled effect size on the total scores of the validated 
QOL scales was marginally significant (SMD = 0.25; 95% CI, -0.03 to 0.54; p = 0.08). 
Study quality assessment and risk of bias  
Of the included eight RCTs, three were reported to be pilot studies40, 42, 46 and additional three 
were registered phase II RCTs.16, 41, 44 The study phase was unclear for the remaining two.15, 43 
As assessed with the TIDieR checklist (Table 2), nearly all of the included studies described the 
intervention in sufficient detail. Only one study16 did not report the location of the intervention 
and three studies41-43 did not address planned measurement of adherence. Actual adherence to 
the intervention was measured in all studies. All described the information materials, 
intervention procedures, and the timeframe and frequency of the intervention.  Table 3 presents 
the study quality assessment for each trial. One RCT41 can be ranked as a high-quality study. 
Allocation concealment was unclear in two RCTs,42, 43 and blinding of outcome assessors was 
unclear in most of the included RCTs, except two.40, 41 Incomplete outcome data were evident 
in all of the included RCTs, and only one RCT43 perform intention-to-treat analyses. Attrition 
rates in the included RCTs ranged from 12%15 to 60%.16 Only in two RCTs,41, 46 sample size 
was larger than 100. Free of selective reporting was unclear in 3 RCTs,42-44 and free of other 
bias was unsure in most of the included RCTs.  
Discussion 
In this review, clinical trial evidence of the effects of therapeutic life review on different health 
outcomes in patients with terminal or advanced cancer was examined and synthesized. A total 
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of 8 RCTs was included. Our results of meta-analysis suggested favorable effects of therapeutic 
life review on spiritual well-being, psychological distress, and overall QOL. These findings are 
in line with the results of systematic reviews of the effects of spiritual interventions in patients 
with cancer.49,50 Similar to spiritual interventions, however, our results did not support long-
term effects of therapeutic life review interventions on spiritual well-being and psychological 
distress, possibly due to the deteriorating physical and mental condition of terminally-ill cancer 
patients.49 Maybe the favorable effects of therapeutic life review could be maintained through 
regular review of the life review document or album. None of the included studies have 
addressed this point, which should be verified in further studies.  
Specifically, our results suggest a favorable effect of therapeutic life reviews on the meaning of 
life domain but not on the faith domain of spiritual well-being. This is in line with the 
hypothesis proposed by Ando and colleagues that an effect on faith issues seems impossible 
following a short period of psychological intervention.15 Our results suggested a desirable 
effect of therapeutic life review on general distress level but not on anxiety and depressive 
symptoms. Furthermore, our results indicated a desirable effect of therapeutic life review on 
overall QOL measured with single-item or 2-item scales. The effect on the total scores of 
validated QOL measures was only marginally significant. Of the three outcomes examined in 
this review, only the pooled effect size of life review interventions on overall QOL remained 
statistically significant at follow-ups up to 3 months after the intervention. Although a single-
item scale cannot completely replace comprehensive and multidimensional questionnaire, it is a 
valid, reliable, and responsive instrument and is recommended in clinical trials,51 particularly 
for patients who are seriously ill as comprehensive assessment is not practical for them.52 Thus, 
our results regarding the effect of life review interventions on QOL are still informative.   
A strength of this review may be that it provides high-quality cumulative evidence from well-
designed clinical trials that therapeutic life review interventions are potentially effective in 
facilitating a sense of life meaning, alleviating psycho-existential suffering, and improving 
QOL for terminally-ill patients. Given the limited number of clinical trials and high risk of bias 
inherent in these trials, however, the results should be interpreted and generalized with caution. 
First, the therapeutic life review was provided to the participants through different strategies 
that were based on various concepts such as dignity, meaning, forgiveness, and life completion. 
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Although these strategies shared a core component of life review, their focuses and intensity of 
performance might be different. Moreover, there was a great disparity in the frequency or 
dosage of intervention and in the duration of follow ups across the trials. It also remains unclear 
about the optimal time to deliver the interventions. All of these may make it a bit difficult to 
compare the results across the trials. Given that therapeutic life review is often delivered in an 
individualized approach and a flexible way, a practical guideline to maintain an adequate 
degree of standardization may be required in this field so as to minimize the patient’s burden 
and performance bias and to maximize effectiveness.  
Second, high risk of attrition bias might be a particular concern for the included RCTs due to 
high attrition rates as a result of death or deterioration of some participants. In addition, few of 
the included studies had screened the participants by distress levels. This might have weakened 
the evidence since participants with less distress had little room to improve following 
intervention than those with more distress.41, 46 Moreover, sample size was relatively small in 
most of the included RCTs, which might have resulted in type-II errors or inadequate power.   
Third, although sequence-generation and allocation concealment were adequate in most of the 
included trials, it was rare and difficult to blind the participants and investigators to the face-to-
face interviews. Thus, the desirable changes of some outcomes in the intervention groups might 
result from Hawthorne effects such as the expectations of the participants and researchers.43 
Furthermore, blinding of outcome assessors was not confirmed in six RCTs. Thus it was 
possible that detection bias might have been introduced in these trials.  
Lastly and notably, the pooled effect for each outcome was statistically significant mainly due 
to the very large effect reported in one relevant trial. As shown in Figure 2, Ando and 
colleagues15 reported a very large interventional effect on the meaning domain of spiritual well-
being and on the general distress level, respectively. Xiao and colleagues43 reported a very 
large effect on overall QOL measured with a single-item scale. After removing the trial from 
relevant model of meta-analysis, the pooled effect become insignificant. Thus, the available 
evidence on the effectiveness of therapeutic life review is not robust, and needs to be further 
confirmed. Given that the two aforementioned studies were conducted within the socio-cultural 
contexts different from that of other studies, the effectiveness of therapeutic life review for 
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individuals of different ethnicities or within different sociocultural contexts needs to be further 
examined and differentiated.  
Our review has some limitations. The first one may be that the effects of different dosages and 
intensity of the interventions and the effects of different strategies were not differentiated due to 
the limited number of the included trials. These issues should be addressed in the future. 
Another limitation may be the potential incompleteness of the evidence reviewed. It is a 
common concern for any systematic reviews. In addition, we have not contacted with relevant 
authors to identify unpublished or ongoing studies. Thus, publication bias might have existed 
for the included studies and the effect sizes of the therapeutic life reviews might have been 
overestimated or underestimated. Finally, we did not include the participants with other 
terminal illnesses, which may limit the generalizability of the findings. Despite these 
limitations, our review is the first to synthesize the available evidence on the effectiveness of 
therapeutic life review interventions on different outcomes among terminally ill patients, which 
may provide insight for further studies. Given that end of life care is being included in the 
global health agenda,53 the findings of this review may be useful for or informative to a wide 
range of professionals and practitioners.  
Conclusions 
In conclusion, this review shows that therapeutic life review interventions may be potentially 
effective in facilitating a sense of life meaning, alleviating psycho-existential suffering, and 
improving QOL among cancer patients near the end of life. Given the risk of bias in the 
included trials, further rigorously designed RCTs that adhere to accepted standards of trial 
methodology, include large-scale, well-defined, multi-centered samples, and use sensitive 
outcome measures are warranted.  
Clinical implications  
Therapeutic life review as an effective approach has been applied for depression in the elderly 
for a long period of time.12 Only in recent years has it been used as a palliative care approach to 
relieve psycho-existential suffering of terminally ill patients. To date, therapeutic life review is 
not widely used in end-of-life care practice yet.9 Despite the risk of bias in the included trails, 
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our results indicate that therapeutic life review interventions may be potentially promise in 
helping terminally ill patients to address their existential suffering, improve their QOL, and 
promote good death. Although the available evidence, as indicted by the pooled effects of meta-
analyses, is not robust, seven of the included eight RCTs have suggested a favorable effect of 
therapeutic life review on one or more outcomes. Thus, it may be necessary to promote 
therapeutic life review as a palliative care approach and integrate it into end-of-life care 
practice so as to enhance the psycho-spiritual well-being of terminally ill patients. As pointed 
out by Chochinov and colleagues, the purpose and potential benefit of therapeutic life review 
for terminally ill patients is not solely the symptomatic relief of stress, but also for the 
prevention of distress, promotion of wellbeing, and establishment of a sense of personal 
meaning and life purpose.41 Such practice may help to improve the quality of end-of-life care 
for individuals facing death, and to support the patients and their families in the best way.  
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Table 1. Summary of included studies  
Studies  Participants N (pre-/post-) Dosage of intervention 
 
Follow up  Control  Outcome measures  Results  
Ando et al., 201015 Terminal cancer patients from 
palliative care units  
65±14 years  
IG:38/34 
CG: 39/34 
Two sessions with a 
one-week interval  
30-60 min/session 
- General support only  1. FACIT-Sp-M 
2. HADS 
1. P < 0.001 
2. P < 0.001 
 
Hall et al., 201116    
 
Patients with advanced cancer 
who were referred to 
palliative care teams  
65±18 years  
IG: 22/12/8 
CG:23/15/10 
Two sessions  
30-60 min/session 
4 weeks  Standard palliative care 1. HADS 
2. QOL (2 items)  
3. QOL (EQ-5D)  
1. NS  
2. NS 
3. NS 
Henry et al., 201040  Advanced ovarian cancer 
patients (stage III or IV)  
55±9.7 years  
IG: 15/12/12 
CG: 13/12/12  
1-4 sessions  
30-90 min/session  
3 months Usual care  1. FACIT-Sp-M 
2. MQOL 
3. HADS 
1. P = 0.04 
2. P = 0.07 
3. P = 0.54  
Chochinov et al., 201141  Terminal cancer patients with 
a life expectancy of 6 months 
or less  
65.1±14.4 years  
IG: 165/108 
CG1: 140/111 
CG2: 136/107  
Three sessions  
30-60 min/session  
- CG1: standard palliative care  
CG2: client-centred care 
(focusing on here-and-now 
issues) 
1. FACIT-Sp 
2. HADS 
3. QOL (2 items)  
1. P = 0.006**  
2. P = 0.009  
3. P = 0.001  
Mok et al., 201242 Patients with advanced-stage 
cancer from oncology wards 
64.6±11.6 years   
IG: 44/34/29 
CG:40/38/29 
2 sessions with a 2-3-
days interval  
15-60 min/session  
2 weeks  Usual care  1. Overall QOL(single-item)  
2. QOLC-E 
1. P < 0.05 
2. P < 0.05 
Xiao et al., 201343 Patients with advanced cancer 
from a home-based hospice  
59±11 years  
IG: 40/35/31 
CG:40/37/30 
3 sessions  
Once a week  
3 weeks  Routine care  1. Overall QOL(single-item)  
2. QOLC-E 
1. P < 0.01 
2. P < 0.01 for 5/8 subscales  
Julião et al., 201444, 45   Terminal patients from a 
palliative care unit (cancer 
patients over 92%)  
66.1±12.9 years  
IG: 39/31/22/17 
CG:41/37/28/19 
Two sessions  
30-60 min/session 
1 month  Standard palliative care  HADS  P = 0.043 for depression  
P = 0.013 for anxiety  
Breitbart et al., 201246  Patients with advanced cancer 
(stage III or IV) 
54.4±11.6 years  
IG: 64/41/33 
CG: 56/37/34 
7 sessions  
Once a week  
60 min/session  
2 months Therapeutic massage  1. FACIT-Sp 
2. MQOL 
3. HADS 
1. P < 0.001  
2. P = 0.013  
3. NS   
CG: control group; EQ-5D: EuroQol five dimensions questionnaire; FACIT-Sp: Functional Assessment of Chronic Illness Therapy-Spiritual scale; FACIT-Sp-M: Functional Assessment of Chronic Illness 
Therapy-Spiritual scale-Meaning of life subscale; HADS: Hospital Anxiety and Depression Scale; IG: intervention group; MQOL: McGill Quality of Life Questionnaire; GSES: General Self-Efficacy Scale; 
BHS: Beck Hopelessness Scale; QOLC-E: Quality-of-Life Concerns in the End-of-Life questionnaire;  
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Table 2: The Template for Intervention Description and Replication (TIDieR) checklist   
 
Studies Name Why Materials Procedures Who How Where When and 
how much 
Tailoring Modifications Planned 
adherence 
Actual 
adherence 
Ando et al., 201015 √ √ √ √ √ √ √ √ √ NA √ √ 
Hall et al., 201116 √ √ √ √ √ √ NS √ √ NA √ √ 
Henry et al., 201040 √ √ √ √ √ √ √ √ √ NA √ √ 
Chochinov et al., 201141 √ √ √ √ √ √ √ √ √ NA NS √ 
Mok et al., 201242 √ √ √ √ √ √ √ √ √ NA NS √ 
Xiao et al., 201343 √ √ √ √ √ √ √ √ √ NA NS √ 
Julião et al., 201444 √ √ √ √ √ √ √ √ √ NA √ √ 
Breitbart et al., 201246 √ √ √ √ √ √ √ √ √ NA √ √ 
NA: not applicable; NS: not specified  
 
 
 
 
 
 
 
 
 
 
 
 
 
Page 23 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
22 
 
 
 
Table 3 Quality assessment for included randomized controlled trials 
 
Studies Adequate sequence 
generation 
Allocation 
concealment 
Blinding of 
outcome assessors 
Incomplete outcome 
data 
Intention-to-treat 
analysis 
Free of selective 
reporting 
Free of other bias 
Ando et al., 201015 Y Y unclear Y N Y unsure 
Hall et al., 201116 Y Y unclear Y N Y unsure 
Henry et al., 201040 Y Y Y Y N Y unsure 
Chochinov et al., 201141 Y Y Y Y N Y Y 
Mok et al., 201242 Y unclear unclear Y N unsure unsure 
Xiao et al., 201343 Y unclear unclear Y Y unsure unsure 
Julião et al., 201444 Y Y unclear Y N unsure unsure 
Breitbart et al., 201246 unclear Y unclear Y N Y Y 
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Figure 1. PRISMA Flow Diagram of study selection  
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a. The effects on spiritual well-being at post-intervention 
b. The effects on psychological distress at post-intervention 
c. The effects on quality of life at post-intervention 
i. The effects on spiritual well-being at follow-ups 
ii. The effects on psychological distress at follow-ups  
iii. The effects on quality of life at follow-ups 
Figure 2  Forest plots of the meta-analyses of the data from relevant RCTs 
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Abstract 
Background: Life review interventions have been used to alleviate psycho-spiritual distress in 
people near the end of life. However, their effectiveness remains inconclusive.  
Aim: To evaluate the effects of therapeutic life review on spiritual well-being, psychological 
distress, and quality of life (QOL) in patients with terminal or advanced cancer. 
Design: A systematic review according to the PRISMA methodology.  
Data sources: Five databases were searched from their respective inception through August 
2016 for relevant randomized controlled trials (RCTs). The effects of therapeutic life review 
were pooled across the trials. Standardized mean differences (SMDs) were calculated for the 
pooled effects. Heterogeneity was assessed using the I2 test. Study quality was assessed using 
the Cochrane criteria.  
Results: Eight RCTs met the inclusion criteria. The pooled results suggested a desirable effect 
of therapeutic life review on the meaning of life domain of spiritual well-being (SMD = 0.33; 
95% CI, 0.12 to 0.53), general distress (SMD = -0.32; 95% CI, -0.55 to -0.09) and overall QOL 
(SMD = 0.35; 95% CI, 0.15 to 0.56) when compared to usual care only. Of the three outcomes 
examined, only the pooled effect on overall QOL remained statistically significant at follow-
ups up to 3 months after the intervention (SMD = 0.82; 95% CI, 0.47 to 1.18).  
Conclusions: Therapeutic life review is potentially beneficial for people near the end of life. 
However, the results should be interpreted with caution due to the limited number of RCTs and 
associated methodological weaknesses. Further rigorously designed RCTs are warranted. 
Keywords: cancer, end of life care, life review, oncology, palliative care, psychotherapy, quality 
of life, spirituality, systematic review  
 
Page 28 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
3 
 
Background 
Existential suffering is a major concern for many persons near the end of life, especially for 
those with a terminal illness and possible premature death.1 It is “the distressed state of 
individuals confronting their own mortality and arising from the consequent feelings of 
powerlessness, hopelessness, meaninglessness, futility, remorse, death anxiety, and disruption 
of personal identity” (p.1022).2 Thus, it is one of the most important factors that contribute to 
decreased QOL among those approaching death.3 If left unattended, it may result in anxiety, 
depression, desire for a hastened death, and suicidal ideation.1, 4 Existential or spiritual distress 
not only adds to patient and family suffering, but also presents a huge challenge for care 
professionals in the provision of end-of-life care.2, 5, 6    
According to World Health Organization, relief of existential suffering in terminally ill patients 
is a major component of palliative care - an approach aiming to improve the QOL of patients 
and their families facing the problems associated with a life-threatening illness through 
prevention and relief of suffering as well as treatment of pain and other physical, psychosocial, 
and spiritual problems.7 It is increasingly emphasized by care professionals, dying persons and 
family members. Practically, existential or spiritual concerns can be addressed using different 
approaches. In addition to the traditional approach which is often related to religious practice 
and connects human experience to nature and to the significant or sacred, therapeutic life 
review, which helps the patients to experience their connectedness to the moment, self and 
others so as to find meaning and purpose in one’s life, is considered an effective psycho-
spiritual intervention to alleviate existential/spiritual distress for people facing the challenge of 
death. It is a process of recalling, reevaluating, and reintegrating life experiences in the final 
stage of life.8, 9 Unlike reminiscence which focuses on recalling memorable and pleasurable 
events from the past, therapeutic life review includes the intention of resolving and integrating 
past conflicts, thus giving new significance to an individual’s life and bringing peace to the 
individual.8-10 Various studies indicated that life review therapy might reduce depression in the 
elderly, enhance their life satisfaction, self-esteem, and QOL.11-14   
According to a process model,15 the beneficial effects of life review can be achieved through 
three different pathways: life completion, burden relief, and hope promotion. First, through 
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reviewing their life history, family lives, attainments and social roles, patients can achieve 
personally meaningful goals and confirm self-identity and/or self-continuity, resulting in 
increased feeling of life completion and peace as well as elevated spiritual well-being. Second, 
through reviewing memories of bringing up children and taking care of family members, 
patients can view their present state with balance, which may decrease their feeling of being a 
burden and thus relief psychological distress. Finally, life review interviews may improve 
patients’ feelings about relationships with family members through a review of life history and 
allow patients to look forward to their progeny’s future growth and increase their hope. The 
beneficial effect on hope has been evident among patients with advanced cancer.16   
In recent years, an increasing number of clinical trials have examined the effects of therapeutic 
life review on different health outcomes among terminally ill patients, but the findings are 
inconsistent. Two systematic reviews have summarized relevant studies in the field,9, 17 but the 
results of those studies have not been synthesized. The effectiveness of therapeutic life review 
on health for terminally ill patients remains inconclusive. To date, the literature lacks a 
systematic review and meta-analysis of the clinical trial evidence in this field. To facilitate 
evidence-based end-of-life care practices, results of relevant clinical trials must be pooled. 
Thus, the purpose of this systematic review was to critically assess and synthesize the clinical 
evidence available from RCTs of the effects of therapeutic life review interventions on spiritual 
well-being, psychological distress, and QOL among patients with terminal or advanced cancer. 
Methods 
This review followed the procedure recommended by the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) statement.18 
Eligibility criteria 
The following criteria were applied for study selection. (1) Types of studies. All RCTs 
evaluating the effects of therapeutic life review on different health outcomes among patients 
with terminal or advanced cancer were included. Nonrandomized controlled trials and 
uncontrolled observational studies were excluded. (2) Types of participants. Study population 
of the intervention should be cancer patients near the end of life and aged 18 years and older. 
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Studies that included newly diagnosed cancer patients, usually at stage I or II, were excluded. 
Studies that included a substantial proportion of the patients with non-cancer terminal illness 
(>10%) were also excluded due to disparities in trajectories of decline leading to death and in 
physical and mental conditions.19 (3) Types of intervention. Given the focus of this review on 
therapeutic life review in particular, rather than on spiritual interventions or psychotherapies in 
general, we excluded the studies that addressed here-and-now issues and the studies that 
connected the patients to nature or to the sacred, as well as the studies of reminiscence. As an 
individual approach was often applied in clinical practice to ensure that the patients felt free to 
reveal their life experiences, studies of group therapy were excluded. (4) Types of controls. All 
included studies had to include a control group of either no psychological intervention or a 
placebo intervention. (5) Types of outcomes. The included studies should include such 
outcomes as spiritual well-being, psychological distress, and/or QOL.  
The literature search 
The following electronic databases were searched initially in August 2016 and re-searched in 
February 2017: CINAHL, Cochrane Library, PsycINFO, PubMed, and Web of Science. The 
following terms were used with such a search string: ‘‘(life review or meaning of life 
intervention or meaning-making intervention or meaning reconstruction or narrative therapy or 
meaning-centered psychotherapy or preparation and life completion or dignity therapy or 
forgiveness therapy or legacy activities or reflective journaling or outlook or story-telling) and 
(terminally ill or seriously ill or life-threatening or end of life or palliative care or advanced 
cancer or advanced-stage cancer).” These terms were identified from relevant articles and 
review papers. We searched the databases for articles containing these terms in the title, abstract 
or keywords from their respective inception through February 2017. Although this review 
mainly included studies published in English, studies in other languages with abstracts in 
English were also examined if available. The reference lists of all included studies and relevant 
reviews were searched manually for other articles.  
Data extraction and quality assessment 
Study selection, data extraction and quality assessment were conducted by one main researcher 
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(CW) and then verified by other researchers (AC, CC). Any discrepancies were resolved by 
discussion. From each of the included trials, we extracted the following information: type of 
participants, number of participants, type of intervention; dosage of the intervention, duration 
of follow up, type of control, outcomes, and results. For the results of each trial, we extracted 
the data on mean, standard deviation and sample size for each outcome in each group at post-
intervention and at follow-up for meta-analyses. Where median and range rather than mean and 
standard deviation were presented, the trial was not included in meta-analyses due to data 
incompatibility. Where the intervention group was compared with two different control groups 
(standard palliative care, client-centered care), we extracted the data of the control group with 
standard palliative care for meta-analysis. The data of another control group were not extracted 
since they might not be comparable with relevant data from other trials. Where outcomes were 
measured at more than one time-point during the follow-up, we used the data at the last time-
point for meta-analyses of follow-up data. For expected but unavailable outcome data, we 
contacted the correspondence author via e-mail for more information.  
The TIDieR (Template for Intervention Description and Replication) checklist20 was used to 
assess the quality of intervention description in each article. The checklist contains 12 items, 
including the intervention name; intervention rationale; information materials used in the 
intervention, intervention procedures; intervention providers; mode of delivery of intervention; 
location of intervention delivery; frequency, intensity and dose of the intervention; intervention 
tailoring; intervention modiﬁcations; intervention ﬁdelity assessment, and actual intervention 
adherence. The Cochrane Collaboration’s assessment tool21 was used to assess the quality of 
whole study for each trial. This tool assesses study quality based on seven criteria: adequate 
randomization; allocation concealment; blinding of participants, personnel, and outcome 
assessors; incomplete outcome data reporting; intention-to-treat analysis; selective outcome 
reporting; and other bias. Since blinding both participants and personnel are generally 
impossible for studies of face-to-face interventions, we only assessed if the outcome assessors 
were blind to the treatment allocation. Based on these criteria, four major categories of bias 
could be evaluated: selection bias (biased allocation), performance bias (unequal provision of 
care apart from the intervention), detection bias (biased assessment of outcomes), and attrition 
bias (biased occurrence of loss to follow up).21 Reporting bias was assessed by examining 
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whether all expected outcome data were reported. “Other bias” was mainly assessed according 
to sample size justification, protocol registration, and other relevant information. 
Data synthesis and analysis 
The reported effects of intervention on each outcome in relevant RCTs were separately pooled 
using Review Manager 5.3 (http://ims.cochrane.org/revman). Standardized mean differences 
(SMDs) were calculated for the pooled effects, which were interpreted using the following rule 
of thumb: 0.2 represents a small effect, 0.5 a moderate effect, and 0.8 a large effect.22 A fixed-
effects model was used when an outcome was measured by the same instrument in different 
studies, and a random-effects model was used for data synthesis when an outcome was 
measured by different measures. Heterogeneity was tested with the I2 statistic. A I2 value of less 
than 75% were considered as high degree of heterogeneity, 50-75% as moderate, and 25-50% 
as low degree of heterogeneity.23 Sensitivity was examined by assessing the impact of a single 
study on the pooled overall effect through omitting one study in turn. Publication bias was not 
assessed due to the limited number of trials (< 10) included in each analysis.21  
Results 
Results of the literature search 
Our searches identified 1387 records. After removal of duplications, 1012 records remained. Of 
them, 986 records were excluded after screening titles and abstracts. Full reports of 26 
publications were acquired and 17 publications were further excluded, including 6 uncontrolled 
trials,10, 24-28 1 study with quasi experimental design,29 1 study with yoked control design,30 and 
9 RCTs that did not meet the inclusion criteria31-39 (Figure 1). 
Characteristics of included studies 
Nine reports on 8 RCTs published between 2010 and 2014 met the inclusion criteria. They were 
conducted in Canada,40, 41 Hong Kong,42 Japan,15 Mainland China,43 Portugal,44, 45 UK,16 and 
USA.46 All of them were published in English in peer-reviewed journals. Table 1 presents the 
characteristics of the included RCTs.  
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All included RCTs focused on patients with terminal or advanced cancer. The sample sizes 
ranged from 28 to 441, with a median of 80 and a total of 955 participants, including 427 in the 
intervention groups and 528 in the control groups, respectively. The types of intervention 
included short-term life-review,15 life review,43 dignity therapy,16, 41, 44, 45 meaning-making 
intervention,40 meaning of life intervention,42 and meaning-centered psychotherapy.46 
Frequencies of intervention ranged from single session40 to seven sessions,46 with 2 sessions in 
four RCTs15,16,42,44 and 3 sessions in two RCTs.41,43 The participants were followed up in 6 
RCTs16,40,42-44,46 for a period of time ranging from 2 weeks42 to 3 months.40  
Nearly all of the included RCTs used a two-armed, parallel-group design, except one with three 
arms. The intervention groups were usually compared with standard palliative care or usual 
care groups. Only in one RCT, the life review intervention was compared to therapeutic 
massage.46 Outcomes were measured at two time points (including baseline) in two RCTs,15, 41 
at three time points in 5 RCTs,16, 40, 42, 43, 46 and at four time points in one RCT.44 Spiritual well-
being was assessed with the Functional Assessment of Chronic Illness Therapy-Spiritual 
(FACIT-Sp) Scale.15, 40, 41, 46 Psychological distress was assessed with the Hospital Anxiety and 
Depression scale (HADS).15, 16, 40, 44, 46 QOL was evaluated with different measures, including a 
single-item QOL scale,43 a 2-item QOL scale,16, 41 EuroQol five dimensions questionnaire (EQ-
5D),16 the McGill Quality of Life Questionnaire (MQOL),40, 46 and Quality-of-Life Concerns in 
the End-of-Life questionnaire (QOLC-E).42, 43    
Pooled effects of the life review therapies on different outcomes  
Meta-analyses of the data were performed for 7 RCTs. Two publications on the same RCT were 
not included in the meta-analyses since the data with median and range rather than mean and 
standard deviation were presented in the publications.44, 45 In another RCT,46 the participants in 
the control group who received physical massage could be taken as those who received a 
placebo intervention. Although there is evidence that the use of massage therapy may reduce 
pain, anxiety and depression in oncological palliative care patients,47  a RCT with terminally ill 
patients produced no evidence of benefit from massage, when evaluated with measures of 
global QOL and pain distress over the course of patient participation.48 Moreover, there is no 
evidence of any effect of massage on spiritual well-being so far. Thus, the data of this group 
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were pooled with relevant data from other RCTs.  
(1) Spiritual well-being  
Four RCTs15, 40, 41, 46 examined the effect of therapeutic life review on spiritual well-being. Of 
them, 3 RCTs15, 40, 46 suggested a beneficial effect on the meaning domain and one RCT46 
suggested a beneficial effect on the faith domain of spiritual well-being immediately at post-
intervention. Only one RCT suggested that the beneficial effect on the meaning domain 
remained 3 months later.40 Their results were pooled, respectively. The pooled effect size was 
statistically significant only for the meaning domain at post-intervention (SMD = 0.33; 95% CI, 
0.12 to 0.53; p = 0.002). There was a high degree of heterogeneity (I2 = 91%, Figure 2). After 
excluding the trial by Ando et al.,15 the pooled effect become insignificant (SMD = 0.10; 95% 
CI, -0.12 to 0.32; p = 0.36; I2 = 30%). Exclusion of any other single trial did not significantly 
alter the pooled effect. 
(2) Psychological distress  
Six RCTs15, 16, 40, 41, 44, 46 examined the effects of life review therapies on psychological distress. 
Of them, only one15 suggested a desirable effect on general distress as indicated by the total 
score of HADS and another RCT44 suggested beneficial effects on both anxiety and depression 
symptoms at post-intervention. No beneficial effect on psychological distress was observed at 
follow-up in any RCT. Apart from one RCT in which the data with median and range were 
presented,44 the results of these trials were pooled for each outcome, and the pooled effect size 
was statistically significant only for general distress levels at post-intervention (SMD = -0.32; 
95% CI, -0.55 to -0.09; p = 0.007). There was a high degree of heterogeneity (I2 = 93%, Figure 
2). After excluding the trial by Ando et al.,15 the pooled effect size become insignificant (SMD 
= -0.03; 95% CI, -0.29 to 0.22; p = 0.79, I2 = 4%). Exclusion of any other single trial did not 
significantly alter the pooled effect.  
(3) Quality of life  
Six RCTs16, 40-43, 46 examined the effect of life review therapies on QOL. A single-item or 2-item 
scale was applied in 4 RCTs and a validated scale was applied in 5 RCTs (Table 1). The total 
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score of the validated scale was not available in one RCT.43 The available results from these 
RCTs were pooled. The pooled effect size was statistically significant for overall QOL 
measured with single-item or 2-item scales at post-intervention (SMD = 0.35; 95% CI, 0.15 to 
0.56; p < 0.001) and at follow-ups (SMD = 0.82; 95% CI, 0.47 to 1.18; p < 0.0001). There was 
a high degree of heterogeneity (I2 = 91% and 90%, respectively, Figure 2). After excluding the 
trial by Xiao et al.,43 the pooled effect sizes for overall QOL become insignificant at post-
intervention (SMD = 0.10; 95% CI, -0.13 to 0.32; p = 0.40; I2 = 0%) and at follow-ups (SMD = 
0.04; 95% CI, -0.45 to 0.53; p = 0.88; I2 = 0%). Exclusion of any other single trial did not 
significantly alter the pooled effect. The pooled effect size on the total scores of the validated 
QOL scales was marginally significant (SMD = 0.25; 95% CI, -0.03 to 0.54; p = 0.08). 
Study quality assessment and risk of bias  
Of the included eight RCTs, three were reported to be pilot studies40, 42, 46 and additional three 
were registered phase II RCTs.16, 41, 44 The study phase was unclear for the remaining two.15, 43 
As assessed with the TIDieR checklist (Table 2), nearly all of the included studies described the 
intervention in sufficient detail. Only one study16 did not report the location of the intervention 
and three studies41-43 did not address planned measurement of adherence. Actual adherence to 
the intervention was measured in all studies. All described the information materials, 
intervention procedures, and the timeframe and frequency of the intervention.  Table 3 presents 
the study quality assessment for each trial. One RCT41 can be ranked as a high-quality study. 
Allocation concealment was unclear in two RCTs,42, 43 and blinding of outcome assessors was 
unclear in most of the included RCTs, except two.40, 41 Incomplete outcome data were evident 
in all of the included RCTs, and only one RCT43 perform intention-to-treat analyses. Attrition 
rates in the included RCTs ranged from 12%15 to 60%.16 Only in two RCTs,41, 46 sample size 
was larger than 100. Free of selective reporting was unclear in 3 RCTs,42-44 and free of other 
bias was unsure in most of the included RCTs.  
Discussion 
In this review, clinical trial evidence of the effects of therapeutic life review on different health 
outcomes in patients with terminal or advanced cancer was examined and synthesized. A total 
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of 8 RCTs was included. Our results of meta-analysis suggested favorable effects of therapeutic 
life review on spiritual well-being, psychological distress, and overall QOL. These findings are 
in line with the results of systematic reviews of the effects of spiritual interventions in patients 
with cancer.49,50 Similar to spiritual interventions, however, our results did not support long-
term effects of therapeutic life review interventions on spiritual well-being and psychological 
distress, possibly due to the deteriorating physical and mental condition of terminally-ill cancer 
patients.49 Maybe the favorable effects of therapeutic life review could be maintained through 
regular review of the life review document or album. None of the included studies have 
addressed this point, which should be verified in further studies.  
Specifically, our results suggest a favorable effect of therapeutic life reviews on the meaning of 
life domain but not on the faith domain of spiritual well-being. This is in line with the 
hypothesis proposed by Ando and colleagues that an effect on faith issues seems impossible 
following a short period of psychological intervention.15 Our results suggested a desirable 
effect of therapeutic life review on general distress level but not on anxiety and depressive 
symptoms. Furthermore, our results indicated a desirable effect of therapeutic life review on 
overall QOL measured with single-item or 2-item scales. The effect on the total scores of 
validated QOL measures was only marginally significant. Of the three outcomes examined in 
this review, only the pooled effect size of life review interventions on overall QOL remained 
statistically significant at follow-ups up to 3 months after the intervention. Although a single-
item scale cannot completely replace comprehensive and multidimensional questionnaire, it is a 
valid, reliable, and responsive instrument and is recommended in clinical trials,51 particularly 
for patients who are seriously ill as comprehensive assessment is not practical for them.52 Thus, 
our results regarding the effect of life review interventions on QOL are still informative.   
A strength of this review may be that it provides high-quality cumulative evidence from well-
designed clinical trials that therapeutic life review interventions are potentially effective in 
facilitating a sense of life meaning, alleviating psycho-existential suffering, and improving 
QOL for terminally-ill patients. Given the limited number of clinical trials and high risk of bias 
inherent in these trials, however, the results should be interpreted and generalized with caution. 
First, the therapeutic life review was provided to the participants through different strategies 
that were based on various concepts such as dignity, meaning, forgiveness, and life completion. 
Page 37 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
12 
 
Although these strategies shared a core component of life review, their focuses and intensity of 
performance might be different. Moreover, there was a great disparity in the frequency or 
dosage of intervention and in the duration of follow ups across the trials. It also remains unclear 
about the optimal time to deliver the interventions. All of these may make it a bit difficult to 
compare the results across the trials. Given that therapeutic life review is often delivered in an 
individualized approach and a flexible way, a practical guideline to maintain an adequate 
degree of standardization may be required in this field so as to minimize the patient’s burden 
and performance bias and to maximize effectiveness.  
Second, high risk of attrition bias might be a particular concern for the included RCTs due to 
high attrition rates as a result of death or deterioration of some participants. In addition, few of 
the included studies had screened the participants by distress levels. This might have weakened 
the evidence since participants with less distress had little room to improve following 
intervention than those with more distress.41, 46 Moreover, sample size was relatively small in 
most of the included RCTs, which might have resulted in type-II errors or inadequate power.   
Third, although sequence-generation and allocation concealment were adequate in most of the 
included trials, it was rare and difficult to blind the participants and investigators to the face-to-
face interviews. Thus, the desirable changes of some outcomes in the intervention groups might 
result from Hawthorne effects such as the expectations of the participants and researchers.43 
Furthermore, blinding of outcome assessors was not confirmed in six RCTs. Thus it was 
possible that detection bias might have been introduced in these trials.  
Lastly and notably, the pooled effect for each outcome was statistically significant mainly due 
to the very large effect reported in one relevant trial. As shown in Figure 2, Ando and 
colleagues15 reported a very large interventional effect on the meaning domain of spiritual well-
being and on the general distress level, respectively. Xiao and colleagues43 reported a very 
large effect on overall QOL measured with a single-item scale. After removing the trial from 
relevant model of meta-analysis, the pooled effect become insignificant. Thus, the available 
evidence on the effectiveness of therapeutic life review is not robust, and needs to be further 
confirmed. Given that the two aforementioned studies were conducted within the socio-cultural 
contexts different from that of other studies, the effectiveness of therapeutic life review for 
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individuals of different ethnicities or within different sociocultural contexts needs to be further 
examined and differentiated.  
Our review has some limitations. The first one may be that the effects of different dosages and 
intensity of the interventions and the effects of different strategies were not differentiated due to 
the limited number of the included trials. These issues should be addressed in the future. 
Another limitation may be the potential incompleteness of the evidence reviewed. It is a 
common concern for any systematic reviews. In addition, we have not contacted with relevant 
authors to identify unpublished or ongoing studies. Thus, publication bias might have existed 
for the included studies and the effect sizes of the therapeutic life reviews might have been 
overestimated or underestimated. Finally, we did not include the participants with other 
terminal illnesses, which may limit the generalizability of the findings. Despite these 
limitations, our review is the first to synthesize the available evidence on the effectiveness of 
therapeutic life review interventions on different outcomes among terminally ill patients, which 
may provide insight for further studies. Given that end of life care is being included in the 
global health agenda,53 the findings of this review may be useful for or informative to a wide 
range of professionals and practitioners.  
Conclusions 
In conclusion, this review shows that therapeutic life review interventions may be potentially 
effective in facilitating a sense of life meaning, alleviating psycho-existential suffering, and 
improving QOL among cancer patients near the end of life. Given the risk of bias in the 
included trials, further rigorously designed RCTs that adhere to accepted standards of trial 
methodology, include large-scale, well-defined, multi-centered samples, and use sensitive 
outcome measures are warranted.  
Clinical implications  
Therapeutic life review as an effective approach has been applied for depression in the elderly 
for a long period of time.12 Only in recent years has it been used as a palliative care approach to 
relieve psycho-existential suffering of terminally ill patients. To date, therapeutic life review is 
not widely used in end-of-life care practice yet.9 Despite the risk of bias in the included trails, 
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our results indicate that therapeutic life review interventions may be potentially promise in 
helping terminally ill patients to address their existential suffering, improve their QOL, and 
promote good death. Although the available evidence, as indicted by the pooled effects of meta-
analyses, is not robust, seven of the included eight RCTs have suggested a favorable effect of 
therapeutic life review on one or more outcomes. Thus, it may be necessary to promote 
therapeutic life review as a palliative care approach and integrate it into end-of-life care 
practice so as to enhance the psycho-spiritual well-being of terminally ill patients. As pointed 
out by Chochinov and colleagues, the purpose and potential benefit of therapeutic life review 
for terminally ill patients is not solely the symptomatic relief of stress, but also for the 
prevention of distress, promotion of wellbeing, and establishment of a sense of personal 
meaning and life purpose.41 Such practice may help to improve the quality of end-of-life care 
for individuals facing death, and to support the patients and their families in the best way.  
 
 
 
 
Competing interests:  
The authors declared that they have no competing interests.  
 
 
 
Sources of funding:  
None to report  
 
 
 
 
 
 
Page 40 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
15 
 
 
 
 
 
References:  
1. LeMay K, Wilson KG. Treatment of existential distress in life threatening illness: a 
review of manualized interventions. Clin Psychol Rev 2008; 28(3): 472-493.  
2. Kissane DW. Psychospiritual and existential distress. The challenge for palliative care. 
Aust Fam Physician 2000; 29(11): 1022-1025. 
3. Tang ST, Chang WC, Chen JS, Chou WC, Hsieh CH, Chen CH. Associations of 
prognostic awareness/acceptance with psychological distress, existential suffering, and 
quality of life in terminally ill cancer patients' last year of life. Psychooncology. 
2016;25(4):455-62.  
4. Ando M, Morita T, Akechi T. Factors in the Short-term Life Review That Affect 
Spiritual Well-being in Terminally Ill Cancer Patients. J Hosp Palliat Nurs 2010; 12(5): 
305-311.  
5. Breitbart W, Gibson C, Poppito SR, Berg A. Psychotherapeutic Interventions at the End 
of Life: A Focus on Meaning and Spirituality. Can J Psychiat 2004; 49(6): 366-372. 
6. Rousseau P. Spirituality and the dying patient. J Clin Oncol 2000;18(9):2000-2002.  
7. World Health Organization. Innovative care for chronic conditions: Building blocks for 
action. Global report on noncommunicable diseases and mental health. Geneva: WHO 
Press. 2002.  
8. Haber D. Life review: Implementation, theory, research, and therapy. Int J Aging Hum 
Dev 2006; 63(2): 153-171. 
9. Keall RM, Clayton JM, Butow PN. Therapeutic life review in palliative care: a 
systematic review of quantitative evaluations. J Pain Symptom Manage 2015; 49(4): 
747-761.  
10. Ando M, Tsuda A, Morita T. Life review interviews on the spiritual well-being of 
terminally ill cancer patients. Support Care Cancer 2007;15(2):225-231.  
11. Chiang KJ, Lu RB, Chu H, Chang YC, Chou KR. Evaluation of the effect of a life 
review group program on self-esteem and life satisfaction in the elderly. Int J Geriatr 
Psychiatry 2008;23(1):7-10.  
Page 41 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
16 
 
12. Bohlmeijer E, Smit F, Cuijpers P. Effects of reminiscence and life review on late-life 
depression: a meta-analysis. Int J Geriatr Psych 2003;18(12):1088-1094.  
13. Pot AM, Bohlmeijer ET, Onrust S, Melenhorst AS, Veerbeek M, De Vries W. The 
impact of life review on depression in older adults: a randomized controlled trial. Int 
Psychogeriatr 2010;22(4):572-581.  
14. Hanaoka H, Okamura H. Study on effects of life review activities on the quality of life 
of the elderly: A randomized controlled trial. Psychother Psychosom 2004;73(5):302-
311. 
15. Ando M, Morita T, Akechi T, Okamoto T, Japanese Task Force for Spiritual C. Efficacy 
of short-term life-review interviews on the spiritual well-being of terminally ill cancer 
patients. J Pain Symptom Manage 2010;39(6):993-1002.  
16. Hall S, Goddard C, Opio D, Speck PW, Martin P, Higginson IJ. A novel approach to 
enhancing hope in patients with advanced cancer: a randomised phase II trial of dignity 
therapy. BMJ Support Palliat Care 2011;1(3):315-321.  
17. Donato SC, Matuoka JY, Yamashita CC, Salvetti MG. Effects of dignity therapy on 
terminally ill patients: a systematic review. Rev Esc Enferm USP. 2016;50(6):1014-
1024.  
18. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for 
systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.  
19. Lynn J, Adamson DM. Living well at the end of life. Adapting health care to serious 
chronic illness in old age. RAND CORP SANTA MONICA CA; 2003.   
20. Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better 
reporting of interventions: template for intervention description and replication 
(TIDieR) checklist and guide. BMJ 2014;348:g1687. 
21. Higgins JPT, Green S: Cochrane Handbook for Systematic Reviews of Interventions. 
Chichester, UK: Wiley-Blackwell, 2008. 
22. Cohen J. Stastical Power Analysis in the Behavioral Sciences, Lawrence Erlbaum 
Associates, Hillsdale, NJ, USA, 1988. 
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-
analyses. BMJ. 2003;327(7414):557-560.  
24. Chochinov HM, Hack T, Hassard T, Kristjanson LJ, McClement S, Harlos M. Dignity 
Page 42 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
17 
 
therapy: a novel psychotherapeutic intervention for patients near the end of life. J Clin 
Oncol 2005;23(24):5520-5525. 
25. Rosenfeld B, Saracino R, Tobias K, Masterson M, Pessin H, Applebaum A, et al. 
Adapting Meaning-Centered Psychotherapy for the palliative care setting: Results of a 
pilot study. Palliat Med 2017; 31(2):140-146.  
26. Houmann LJ, Chochinov HM, Kristjanson LJ, Petersen MA, Groenvold M. A 
prospective evaluation of Dignity Therapy in advanced cancer patients admitted to 
palliative care. Palliat Med 2014;28(5):448-458.  
27. Keall RM, Butow PN, Steinhauser KE, Clayton JM. Nurse-facilitated preparation and 
life completion interventions are acceptable and feasible in the Australian palliative care 
setting: results from a phase 2 trial. Cancer Nurs 2013;36(3):E39-46.  
28. Ando M, Morita T, Okamoto T, Ninosaka Y. One-week Short-Term Life Review 
interview can improve spiritual well-being of terminally ill cancer patients. Psycho-
Oncol 2008;17(9):885-890.  
29. Ahn SH, An YL, Yoo YS, Ando M, Yoon SJ. Effects of a Short-term Life Review on 
Spiritual Well-being, Depression, and Anxiety in Terminally Ill Cancer Patients. J 
Korean Acad Nurs 2012;42(1):28-35.  
30. Hansen MJ, Enright RD, Baskin TW, Klatt J. A palliative care intervention in 
forgiveness therapy for elderly terminally ill cancer patients. J Palliat Care 
2009;25(1):51-60. 
31. Allen RS, Hilgeman MM, Ege MA, Shuster JL, Jr., Burgio LD. Legacy activities as 
interventions approaching the end of life. J Palliat Med 2008;11(7):1029-1038.  
32. Breitbart W, Rosenfeld B, Pessin H, Applebaum A, Kulikowski J, Lichtenthal WG. 
Meaning-centered group psychotherapy: an effective intervention for improving 
psychological well-being in patients with advanced cancer. J Clin Oncol 
2015;33(7):749-754.  
33. Breitbart W, Rosenfeld B, Gibson C, Pessin H, Poppito S, Nelson C, et al. Meaning-
centered group psychotherapy for patients with advanced cancer: a pilot randomized 
controlled trial. Psychooncology 2010;19(1):21-28.  
34. Hall S, Goddard C, Opio D, Speck P, Higginson IJ. Feasibility, acceptability and 
potential effectiveness of Dignity Therapy for older people in care homes: a phase II 
Page 43 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
18 
 
randomized controlled trial of a brief palliative care psychotherapy. Palliat Med 
2012;26(5):703-712. 
35. Julião M, Oliveira F, Nunes B, Carneiro AV, Barbosa A. Effect of dignity therapy on 
end-of-life psychological distress in terminally ill Portuguese patients: A randomized 
controlled trial. Palliat Support Care. 2017 Feb 7:1-10. [Epub ahead of print] 
36. Lee V, Robin Cohen S, Edgar L, Laizner AM, Gagnon AJ. Meaning-making 
intervention during breast or colorectal cancer treatment improves self-esteem, 
optimism, and self-efficacy. Soc Sci Med 2006;62(12):3133-3145.  
37. Steinhauser KE, Alexander SC, Byock IR, George LK, Tulsky JA. Seriously ill patients' 
discussions of preparation and life completion: an intervention to assist with transition 
at the end of life. Palliat Support Care 2009;7(4):393-404.  
38. Steinhauser KE, Alexander SC, Byock IR, George LK, Olsen MK, Tulsky JA. Do 
preparation and life completion discussions improve functioning and quality of life in 
seriously ill patients? Pilot randomized control trial. J Palliat Med 2008;11(9):1234-
1240. 
39. Vuksanovic D, Green HJ, Dyck M, Morrissey SA. Dignity therapy and life review for 
palliative care patients: a randomized controlled trial. J Pain Symptom Manage. 
2017;53(2):162-170.e1. 
40. Henry M, Cohen SR, Lee V, Sauthier P, Provencher D, Drouin P, et al. The Meaning-
Making intervention (MMi) appears to increase meaning in life in advanced ovarian 
cancer: a randomized controlled pilot study. Psychooncology 2010;19(12):1340-1347. 
41. Chochinov HM, Kristjanson LJ, Breitbart W, McClement S, Hack TF, Hassard T, et al. 
Effect of dignity therapy on distress and end-of-life experience in terminally ill patients: 
a randomised controlled trial. The Lancet Oncology 2011;12(8):753-762.  
42. Mok E, Lau KP, Lai T, Ching S. The meaning of life intervention for patients with 
advanced-stage cancer: development and pilot study. Oncol Nurs Forum 2012; 39(6): 
E480-488.  
43. Xiao H, Kwong E, Pang S, Mok E. Effect of a life review program for Chinese patients 
with advanced cancer: a randomized controlled trial. Cancer Nurs 2013; 36(4): 274-283. 
44. Juliao M, Oliveira F, Nunes B, Vaz Carneiro A, Barbosa A. Efficacy of dignity therapy 
on depression and anxiety in Portuguese terminally ill patients: a phase II randomized 
Page 44 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
19 
 
controlled trial. J Palliat Med 2014;17(6):688-695.  
45. Juliao M, Barbosa A, Oliveira F, Nunes B, Vaz Carneiro A. Efficacy of dignity therapy 
for depression and anxiety in terminally ill patients: early results of a randomized 
controlled trial. Palliat Support Care 2013;11(6):481-489.  
46. Breitbart W, Poppito S, Rosenfeld B, Vickers AJ, Li Y, Abbey J, et al. Pilot randomized 
controlled trial of individual meaning-centered psychotherapy for patients with 
advanced cancer. J Clin Oncol 2012;30(12):1304-1309.  
47. Falkensteiner M, Mantovan F, Müller I, Them C. The use of massage therapy for 
reducing pain, anxiety, and depression in oncological palliative care patients: a narrative 
review of the literature. ISRN Nurs 2011;2011:929868.  
48. Downey L, Diehr P, Standish LJ, Patrick DL, Kozak L, Fisher D, et al. Might massage 
or guided meditation provide "means to a better end"? Primary outcomes from an 
efficacy trial with patients at the end of life. J Palliat Care 2009;25(2):100-108.  
49. Kruizinga R, Hartog ID, Jacobs M, Daams JG, Scherer-Rath M, Schilderman JB, et al. 
The effect of spiritual interventions addressing existential themes using a narrative 
approach on quality of life of cancer patients: a systematic review and meta-analysis. 
Psychooncology 2016;25(3):253-265.  
50. Oh PJ, Kim SH. The effects of spiritual interventions in patients with cancer: a meta-
analysis. Oncol Nurs Forum 2014;41(5):E290-301.  
51. de Boer AGEM, van Lanschot JJB, Stalmeier PFM, van Sandick JW, Hulscher JBF, de 
Haes JCJM, et al. Is a single-item visual analogue scale as valid, reliable and responsive 
as multi-item scales in measuring quality of life? Qual Life Res 2004; 13(2): 311-320.  
52. Stiel S, Psych D, Kues K, Krumm N, Radbruch L, Elsner F. Assessment of quality of 
life in patients receiving palliative care: comparison of measurement tools and single 
item on subjective well-being. J Palliat Med 2011;14(5):599-606.  
53. Harding R, Higginson IJ: Inclusion of end-of-life care in the global health agenda. 
Lancet Glob Health 2014; 2(7):e375-376. 
 
Page 45 of 49
http://mc.http://mc.manuscriptcentral.com/palliative-medicine
Palliative Medicine
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
20 
 
 
Table 1. Summary of included studies  
Studies  Participants N (pre-/post-) Dosage of intervention 
 
Follow up  Control  Outcome measures  Results  
Ando et al., 201015 Terminal cancer patients from 
palliative care units  
65±14 years  
IG:38/34 
CG: 39/34 
Two sessions with a 
one-week interval  
30-60 min/session 
- General support only  1. FACIT-Sp-M 
2. HADS 
1. P < 0.001 
2. P < 0.001 
 
Hall et al., 201116    
 
Patients with advanced cancer 
who were referred to 
palliative care teams  
65±18 years  
IG: 22/12/8 
CG:23/15/10 
Two sessions  
30-60 min/session 
4 weeks  Standard palliative care 1. HADS 
2. QOL (2 items)  
3. QOL (EQ-5D)  
1. NS  
2. NS 
3. NS 
Henry et al., 201040  Advanced ovarian cancer 
patients (stage III or IV)  
55±9.7 years  
IG: 15/12/12 
CG: 13/12/12  
1-4 sessions  
30-90 min/session  
3 months Usual care  1. FACIT-Sp-M 
2. MQOL 
3. HADS 
1. P = 0.04 
2. P = 0.07 
3. P = 0.54  
Chochinov et al., 201141  Terminal cancer patients with 
a life expectancy of 6 months 
or less  
65.1±14.4 years  
IG: 165/108 
CG1: 140/111 
CG2: 136/107  
Three sessions  
30-60 min/session  
- CG1: standard palliative care  
CG2: client-centred care 
(focusing on here-and-now 
issues) 
1. FACIT-Sp 
2. HADS 
3. QOL (2 items)  
1. P = 0.006**  
2. P = 0.009  
3. P = 0.001  
Mok et al., 201242 Patients with advanced-stage 
cancer from oncology wards 
64.6±11.6 years   
IG: 44/34/29 
CG:40/38/29 
2 sessions with a 2-3-
days interval  
15-60 min/session  
2 weeks  Usual care  1. Overall QOL(single-item)  
2. QOLC-E 
1. P < 0.05 
2. P < 0.05 
Xiao et al., 201343 Patients with advanced cancer 
from a home-based hospice  
59±11 years  
IG: 40/35/31 
CG:40/37/30 
3 sessions  
Once a week  
3 weeks  Routine care  1. Overall QOL(single-item)  
2. QOLC-E 
1. P < 0.01 
2. P < 0.01 for 5/8 subscales  
Julião et al., 201444, 45   Terminal patients from a 
palliative care unit (cancer 
patients over 92%)  
66.1±12.9 years  
IG: 39/31/22/17 
CG:41/37/28/19 
Two sessions  
30-60 min/session 
1 month  Standard palliative care  HADS  P = 0.043 for depression  
P = 0.013 for anxiety  
Breitbart et al., 201246  Patients with advanced cancer 
(stage III or IV) 
54.4±11.6 years  
IG: 64/41/33 
CG: 56/37/34 
7 sessions  
Once a week  
60 min/session  
2 months Therapeutic massage  1. FACIT-Sp 
2. MQOL 
3. HADS 
1. P < 0.001  
2. P = 0.013  
3. NS   
CG: control group; EQ-5D: EuroQol five dimensions questionnaire; FACIT-Sp: Functional Assessment of Chronic Illness Therapy-Spiritual scale; FACIT-Sp-M: Functional Assessment of Chronic Illness 
Therapy-Spiritual scale-Meaning of life subscale; HADS: Hospital Anxiety and Depression Scale; IG: intervention group; MQOL: McGill Quality of Life Questionnaire; GSES: General Self-Efficacy Scale; 
BHS: Beck Hopelessness Scale; QOLC-E: Quality-of-Life Concerns in the End-of-Life questionnaire;  
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Table 2: The Template for Intervention Description and Replication (TIDieR) checklist   
 
Studies Name Why Materials Procedures Who How Where When and 
how much 
Tailoring Modifications Planned 
adherence 
Actual 
adherence 
Ando et al., 201015 √ √ √ √ √ √ √ √ √ NA √ √ 
Hall et al., 201116 √ √ √ √ √ √ NS √ √ NA √ √ 
Henry et al., 201040 √ √ √ √ √ √ √ √ √ NA √ √ 
Chochinov et al., 201141 √ √ √ √ √ √ √ √ √ NA NS √ 
Mok et al., 201242 √ √ √ √ √ √ √ √ √ NA NS √ 
Xiao et al., 201343 √ √ √ √ √ √ √ √ √ NA NS √ 
Julião et al., 201444 √ √ √ √ √ √ √ √ √ NA √ √ 
Breitbart et al., 201246 √ √ √ √ √ √ √ √ √ NA √ √ 
NA: not applicable; NS: not specified  
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Table 3 Quality assessment for included randomized controlled trials 
 
Studies Adequate sequence 
generation 
Allocation 
concealment 
Blinding of 
outcome assessors 
Incomplete outcome 
data 
Intention-to-treat 
analysis 
Free of selective 
reporting 
Free of other bias 
Ando et al., 201015 Y Y unclear Y N Y unsure 
Hall et al., 201116 Y Y unclear Y N Y unsure 
Henry et al., 201040 Y Y Y Y N Y unsure 
Chochinov et al., 201141 Y Y Y Y N Y Y 
Mok et al., 201242 Y unclear unclear Y N unsure unsure 
Xiao et al., 201343 Y unclear unclear Y Y unsure unsure 
Julião et al., 201444 Y Y unclear Y N unsure unsure 
Breitbart et al., 201246 unclear Y unclear Y N Y Y 
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Appendix 1: PRISMA 2009 Checklist  
Section/topic  # Checklist item  
Reported 
on page #  
TITLE   
Title  1 Identify the report as a systematic review, meta-analysis, or both.  1 
ABSTRACT   
Structured summary  2 Provide a structured summary including, as applicable: background; objectives; data sources; study eligibility criteria, 
participants, and interventions; study appraisal and synthesis methods; results; limitations; conclusions and 
implications of key findings; systematic review registration number.  
2 
INTRODUCTION   
Rationale  3 Describe the rationale for the review in the context of what is already known.  3-4 
Objectives  4 Provide an explicit statement of questions being addressed with reference to participants, interventions, 
comparisons, outcomes, and study design (PICOS).  
4 
METHODS   
Protocol and registration  5 Indicate if a review protocol exists, if and where it can be accessed (e.g., Web address), and, if available, provide 
registration information including registration number.  
None 
Eligibility criteria  6 Specify study characteristics (e.g., PICOS, length of follow-up) and report characteristics (e.g., years considered, 
language, publication status) used as criteria for eligibility, giving rationale.  
4-5 
Information sources  7 Describe all information sources (e.g., databases with dates of coverage, contact with study authors to identify 
additional studies) in the search and date last searched.  
5 
Search  8 Present full electronic search strategy for at least one database, including any limits used, such that it could be 
repeated.  
5 
Study selection  9 State the process for selecting studies (i.e., screening, eligibility, included in systematic review, and, if applicable, 
included in the meta-analysis).  
Figure 1 
Data collection process  10 Describe method of data extraction from reports (e.g., piloted forms, independently, in duplicate) and any processes 
for obtaining and confirming data from investigators.  
5-6 
Data items  11 List and define all variables for which data were sought (e.g., PICOS, funding sources) and any assumptions and 
simplifications made.  
5-6,  
Tables 1-3 
Risk of bias in individual 
studies  
12 Describe methods used for assessing risk of bias of individual studies (including specification of whether this was 
done at the study or outcome level), and how this information is to be used in any data synthesis.  
6-7 
Summary measures  13 State the principal summary measures (e.g., risk ratio, difference in means).  7 
Synthesis of results  14 Describe the methods of handling data and combining results of studies, if done, including measures of consistency 
(e.g., I
2
) for each meta-analysis.  
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Appendix 1: PRISMA 2009 Checklist  
Section/topic  # Checklist item  
Reported 
on page #  
Risk of bias across studies  15 Specify any assessment of risk of bias that may affect the cumulative evidence (e.g., publication bias, selective 
reporting within studies).  
6 
Additional analyses  16 Describe methods of additional analyses (e.g., sensitivity or subgroup analyses, meta-regression), if done, 
indicating which were pre-specified.  
NA 
RESULTS   
Study selection  17 Give numbers of studies screened, assessed for eligibility, and included in the review, with reasons for exclusions 
at each stage, ideally with a flow diagram.  
7, Figure 1 
Study characteristics  18 For each study, present characteristics for which data were extracted (e.g., study size, PICOS, follow-up period) 
and provide the citations.  
7-8, Table 1 
Risk of bias within studies  19 Present data on risk of bias of each study and, if available, any outcome level assessment (see item 12).  10, Table 3 
Results of individual studies  20 For all outcomes considered (benefits or harms), present, for each study: (a) simple summary data for each 
intervention group (b) effect estimates and confidence intervals, ideally with a forest plot.  
9-10, Table 1 
Synthesis of results  21 Present results of each meta-analysis done, including confidence intervals and measures of consistency.  9-10 
Risk of bias across studies  22 Present results of any assessment of risk of bias across studies (see Item 15).  10 
Additional analysis  23 Give results of additional analyses, if done (e.g., sensitivity or subgroup analyses, meta-regression [see Item 16]).  NA 
DISCUSSION   
Summary of evidence  24 Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to 
key groups (e.g., healthcare providers, users, and policy makers).  
10-11 
Limitations  25 Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of 
identified research, reporting bias).  
13 
Conclusions  26 Provide a general interpretation of the results in the context of other evidence, and implications for future research.  13 
FUNDING   
Funding  27 Describe sources of funding for the systematic review and other support (e.g., supply of data); role of funders for 
the systematic review.  
14 
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